NO20035183D0 - 5-substituerte-2-arylpyridiner som CRF1 modulatorer - Google Patents

5-substituerte-2-arylpyridiner som CRF1 modulatorer

Info

Publication number: NO20035183D0
Authority: NO; Norway
Prior art keywords: arylpyridines; crf1; modulators; substituted; crf1 modulators
Prior art date: 2001-05-22

Application number

NO20035183A

Other languages

English (en)

Inventor

Ping Ge

Taeyoung Yoon

Lu Yan Zhang

Raymond F Horvath

Original Assignee

Neurogen Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-22

Filing date

2003-11-21

Publication date

2003-11-21

2003-11-21 Application filed by Neurogen Corp filed Critical Neurogen Corp

2003-11-21 Publication of NO20035183D0 publication Critical patent/NO20035183D0/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Oncology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

NO20035183A 2001-05-22 2003-11-21 5-substituerte-2-arylpyridiner som CRF1 modulatorer NO20035183D0 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29270301P	2001-05-22	2001-05-22
PCT/US2002/016529 WO2002096421A1 (en)	2001-05-22	2002-05-22	5-substituted-2-arylpyridines as crf1 modulators

Publications (1)

Publication Number	Publication Date
NO20035183D0 true NO20035183D0 (no)	2003-11-21

Family

ID=23125823

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20035183A NO20035183D0 (no)	2001-05-22	2003-11-21	5-substituerte-2-arylpyridiner som CRF1 modulatorer

Country Status (20)

Country	Link
US (2)	US7223778B2 (no)
EP (1)	EP1392302A1 (no)
JP (1)	JP2004531570A (no)
KR (1)	KR20040015716A (no)
AP (1)	AP2003002920A0 (no)
BG (1)	BG108490A (no)
BR (1)	BR0209920A (no)
CA (1)	CA2448198A1 (no)
EC (1)	ECSP034860A (no)
HR (1)	HRP20031056A2 (no)
HU (1)	HUP0400316A2 (no)
IL (1)	IL158958A0 (no)
IS (1)	IS7046A (no)
MX (1)	MXPA03010692A (no)
NO (1)	NO20035183D0 (no)
PL (1)	PL367153A1 (no)
RU (1)	RU2003134010A (no)
SK (1)	SK15432003A3 (no)
TN (1)	TNSN03119A1 (no)
WO (1)	WO2002096421A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2004000318A2 (en)	2002-06-21	2003-12-31	Cellular Genomics, Inc.	Certain amino-substituted monocycles as kinase modulators
US7342115B2 (en) *	2002-11-08	2008-03-11	Neurogen Corporation	3-substituted-6-aryl pyridines
WO2005007627A1 (ja) *	2003-07-18	2005-01-27	Nihon Nohyaku Co., Ltd.	フェニルピリジン誘導体、その中間体及びこれを有効成分とする除草剤
US20070099938A1 (en) *	2003-10-24	2007-05-03	Ono Pharmaceutical Co., Ltd.	Antistress drug and medical use thereof
EP3696174A1 (en)	2005-11-08	2020-08-19	Vertex Pharmaceuticals Incorporated	Heterocyclic modulators of atp-binding cassette transporters
CN101687842B (zh)	2007-05-09	2013-03-06	沃泰克斯药物股份有限公司	Cftr调节剂
ES2382697T3 (es) *	2007-08-01	2012-06-12	Taisho Pharmaceutical Co. Ltd.	Inhibidor de la unión de S1P1
NZ585794A (en) *	2007-12-07	2012-05-25	Vertex Pharma	Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
EP2225230B1 (en)	2007-12-07	2016-11-16	Vertex Pharmaceuticals Incorporated	Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
AU2013205160B2 (en) *	2007-12-07	2016-05-19	Vertex Pharmaceuticals Incorporated	Processes for producing cycloalkylcarboxamido-pyridine benzoic acids
NZ620944A (en)	2008-02-28	2015-02-27	Vertex Pharma	Heteroaryl derivatives as cftr modulators
LT3150198T (lt)	2010-04-07	2021-12-10	Vertex Pharmaceuticals Incorporated	3-(6-(1-(2,2-difluorbenzo[d][1,3]dioksol-5-il) ciklopropankarboksamido)-3-metilpiridin-2-il)benzoinės rūgšties farmacinė kompozicija ir jos įvedimas
IN2014DN08373A (no) *	2012-03-30	2015-05-08	Dow Agrosciences Llc
RU2016122882A (ru)	2013-11-12	2017-12-19	Вертекс Фармасьютикалз Инкорпорейтед	Способ получения фармацевтических композиций для лечения опосредованных cftr заболеваний
US10302602B2 (en)	2014-11-18	2019-05-28	Vertex Pharmaceuticals Incorporated	Process of conducting high throughput testing high performance liquid chromatography
KR101750453B1 (ko)	2015-09-11	2017-06-23	동아대학교 산학협력단	손잡이 세정이 가능한 샤워헤드용 방향제어밸브
US10590083B2 (en)	2017-08-10	2020-03-17	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (I) useful as EP3 receptor antagonists
US10336701B2 (en)	2017-08-10	2019-07-02	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (II) useful as EP3 receptor antagonists
US10399944B2 (en)	2017-08-10	2019-09-03	Janssen Pharmaceutica Nv	Pyridin-2-one derivatives of formula (III) useful as EP3 receptor antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1147068A (en) *	1966-12-02	1969-04-02	Ici Ltd	Phenyl-pyridine derivatives
GB9012017D0 (en) *	1990-05-30	1990-07-18	Ici Plc	Fungicidal compounds
DE4315867A1 (de) *	1993-05-12	1994-11-17	Hoechst Ag	3-Chlorpyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Flüssigkristallmischungen
DE4323916A1 (de) *	1993-07-16	1995-01-19	Basf Ag	Substituierte 2-Phenylpyridine
TW574214B (en) *	1994-06-08	2004-02-01	Pfizer	Corticotropin releasing factor antagonists
US5849758A (en) *	1995-05-30	1998-12-15	American Cyanamid Company	Herbicidal 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines
DE19748439A1 (de) *	1997-11-03	1999-05-06	Hoechst Ag	1,6-Disubstituierte Naphthalinderivate und ihre Verwendung in flüssigkristallinen Mischungen
KR20080021603A (ko) *	2000-02-16	2008-03-07	뉴로젠 코포레이션	치환된 아릴피라진
US20020072521A1 (en) *	2000-03-16	2002-06-13	Taeyoung Yoon	5-substituted arylpyrimidines

2002
- 2002-05-22 BR BR0209920-9A patent/BR0209920A/pt not_active Application Discontinuation
- 2002-05-22 CA CA002448198A patent/CA2448198A1/en not_active Abandoned
- 2002-05-22 SK SK1543-2003A patent/SK15432003A3/sk unknown
- 2002-05-22 US US10/154,396 patent/US7223778B2/en not_active Expired - Fee Related
- 2002-05-22 IL IL15895802A patent/IL158958A0/xx unknown
- 2002-05-22 AP APAP/P/2003/002920A patent/AP2003002920A0/en unknown
- 2002-05-22 KR KR10-2003-7015197A patent/KR20040015716A/ko not_active Application Discontinuation
- 2002-05-22 EP EP02741732A patent/EP1392302A1/en not_active Withdrawn
- 2002-05-22 MX MXPA03010692A patent/MXPA03010692A/es unknown
- 2002-05-22 RU RU2003134010/04A patent/RU2003134010A/ru not_active Application Discontinuation
- 2002-05-22 WO PCT/US2002/016529 patent/WO2002096421A1/en not_active Application Discontinuation
- 2002-05-22 JP JP2002592931A patent/JP2004531570A/ja active Pending
- 2002-05-22 HU HU0400316A patent/HUP0400316A2/hu unknown
- 2002-05-22 PL PL02367153A patent/PL367153A1/xx not_active Application Discontinuation
2003
- 2003-07-08 TN TNPCT/US2002/016529A patent/TNSN03119A1/en unknown
- 2003-11-20 IS IS7046A patent/IS7046A/is unknown
- 2003-11-21 NO NO20035183A patent/NO20035183D0/no not_active Application Discontinuation
- 2003-11-21 EC EC2003004860A patent/ECSP034860A/es unknown
- 2003-12-17 HR HR20031056A patent/HRP20031056A2/hr not_active Application Discontinuation
- 2003-12-22 BG BG108490A patent/BG108490A/bg unknown
2007
- 2007-05-17 US US11/749,840 patent/US20080107608A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002096421A1 (en)	2002-12-05
PL367153A1 (en)	2005-02-21
EP1392302A1 (en)	2004-03-03
HUP0400316A2 (hu)	2005-02-28
BG108490A (bg)	2005-01-31
SK15432003A3 (sk)	2004-05-04
IS7046A (is)	2003-11-20
CA2448198A1 (en)	2002-12-05
TNSN03119A1 (en)	2005-12-23
HRP20031056A2 (en)	2005-08-31
US20080107608A1 (en)	2008-05-08
KR20040015716A (ko)	2004-02-19
US20030152520A1 (en)	2003-08-14
JP2004531570A (ja)	2004-10-14
US7223778B2 (en)	2007-05-29
RU2003134010A (ru)	2005-05-20
ECSP034860A (es)	2004-01-28
MXPA03010692A (es)	2004-07-01
BR0209920A (pt)	2004-03-30
IL158958A0 (en)	2004-05-12
AP2003002920A0 (en)	2003-12-31

Publication	Publication Date	Title
DE50204184D1 (de)	2005-10-13	Espressobrüheinrichtung
DE60209565D1 (de)	2006-04-27	Verstärkermodulation
ATE524462T1 (de)	2011-09-15	C5-modifizierte indazolylpyrrolotriazine
ATE456558T1 (de)	2010-02-15	Gabanerge modulatoren
DE50208022D1 (de)	2006-10-12	Wischblatt
DE50204386D1 (de)	2006-02-09	Kreuztransducer
DE50103741D1 (de)	2004-10-28	Welle-Nabe-Verbindung
NO20035183D0 (no)	2003-11-21	5-substituerte-2-arylpyridiner som CRF1 modulatorer
ATE335486T1 (de)	2006-09-15	Hydrazono-malonitrile
DK1429607T3 (da)	2007-08-13	Delta-1-pyrroliner som pesticider
NO20014597D0 (no)	2001-09-21	Fremgangsmåte
DE50204551D1 (de)	2005-11-17	Kugelgelenk
DE50204794D1 (de)	2005-12-08	Kugelgelenk
DE50203412D1 (de)	2005-07-21	Schwenkkolbenverdränger
DE50203984D1 (de)	2005-09-22	Kugelgelenk
DE60201256D1 (de)	2004-10-21	Elektrooptischer wanderwellenmodulator
ATE355059T1 (de)	2006-03-15	Isoxazolopyridinone
DE60231286D1 (de)	2009-04-09	Optischer Modulator
DE50201862D1 (de)	2005-01-27	Messwandler
DE50203093D1 (de)	2005-06-16	Losradlager
ATE319694T1 (de)	2006-03-15	Phenylalkyne
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
DE50207815D1 (de)	2006-09-21	Kugelgelenk
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE50108381D1 (de)	2006-01-19	Synchronisierschaltungsanordnung

Legal Events

Date	Code	Title	Description
2005-01-03	FC2A	Withdrawal, rejection or dismissal of laid open patent application